{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:25Z","timestamp":1707525385535},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,14]]},"DOI":"10.7759\/cureus.47035","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:28:35Z","timestamp":1697315315000},"source":"Crossref","is-referenced-by-count":0,"title":["Castleman Disease in an Older Patient With the Onset of Right Pleural Effusion"],"prefix":"10.7759","author":[{"given":"Eri","family":"Takao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sora","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000526640","article-title":"Recent advances in Castleman disease","volume":"45","author":"Hoffmann C","year":"2022","unstructured":"Hoffmann C, Hentrich M, Tiemann M, Rosenwald A, Weber F, Willenbacher W, H\u00fcbel K. Recent advances in Castleman disease. Oncol Res Treat. 2022, 45:693-704. 10.1159\/000526640","journal-title":"Oncol Res Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease","volume":"32","author":"Wu D","year":"2018","unstructured":"Wu D, Lim MS, Jaffe ES. Pathology of Castleman disease. Hematol Oncol Clin North Am. 2018, 32:37-52. 10.1016\/j.hoc.2017.09.004","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.5037","article-title":"Diagnosis and management of Castleman disease","volume":"17","author":"Abramson JS","year":"2019","unstructured":"Abramson JS. Diagnosis and management of Castleman disease. J Natl Compr Canc Netw. 2019, 17:1417-9. 10.6004\/jnccn.2019.5037","journal-title":"J Natl Compr Canc Netw"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2021.2021.0440","article-title":"A rare lymphoproliferative disease: Castleman disease","volume":"38","author":"G\u00fcnd\u00fcz E","year":"2021","unstructured":"G\u00fcnd\u00fcz E, \u00d6zdemir N, Bakanay \u015eM, Karaku\u015f S. A rare lymphoproliferative disease: Castleman disease. Turk J Haematol. 2021, 38:314-20. 10.4274\/tjh.galenos.2021.2021.0440","journal-title":"Turk J Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-04762-6","article-title":"Castleman disease and TAFRO syndrome","volume":"101","author":"Masaki Y","year":"2022","unstructured":"Masaki Y, Arita K, Sakai T, Takai K, Aoki S, Kawabata H. Castleman disease and TAFRO syndrome. Ann Hematol. 2022, 101:485-90. 10.1007\/s00277-022-04762-6","journal-title":"Ann Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26292","article-title":"Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease","volume":"96","author":"Nishimura Y","year":"2021","unstructured":"Nishimura Y, Fajgenbaum DC, Pierson SK, et al.. Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease. Am J Hematol. 2021, 96:1241-52. 10.1002\/ajh.26292","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac481","article-title":"Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis","volume":"62","author":"Gonz\u00e1lez Garc\u00eda A","year":"2023","unstructured":"Gonz\u00e1lez Garc\u00eda A, Fern\u00e1ndez-Mart\u00edn J, Robles Marhuenda \u00c1. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis. Rheumatology (Oxford). 2023, 62:1426-35. 10.1093\/rheumatology\/keac481","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000477740","article-title":"Lymphoproliferative disorders of the lung","volume":"94","author":"Borie R","year":"2017","unstructured":"Borie R, Wislez M, Antoine M, Cadranel J. Lymphoproliferative disorders of the lung. Respiration. 2017, 94:157-75. 10.1159\/000477740","journal-title":"Respiration"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2016.05.006","article-title":"Multicentric Castleman disease: where are we now?","volume":"33","author":"Wang HW","year":"2016","unstructured":"Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: where are we now?. Semin Diagn Pathol. 2016, 33:294-306. 10.1053\/j.semdp.2016.05.006","journal-title":"Semin Diagn Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32333","article-title":"Tuberculous pleurisy diagnosed from massive pleural effusion in an older patient with no history of tuberculosis","volume":"14","author":"Nanyoshi M","year":"2022","unstructured":"Nanyoshi M, Amano S, Fujimori T, Sano C, Ohta R. Tuberculous pleurisy diagnosed from massive pleural effusion in an older patient with no history of tuberculosis. Cureus. 2022, 14:e32333. 10.7759\/cureus.32333","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1590\/s1806-37132008000800014","article-title":"Castleman's disease accompanied by pleural effusion","volume":"34","author":"Pinheiro VG","year":"2008","unstructured":"Pinheiro VG, Fernandes GH, Cezar LC, Alves Nde A, de Menezes DB. Castleman's disease accompanied by pleural effusion. J Bras Pneumol. 2008, 34:626-30. 10.1590\/s1806-37132008000800014","journal-title":"J Bras Pneumol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1148\/rg.316115502","article-title":"Castleman disease: the great mimic","volume":"31","author":"Bonekamp D","year":"2011","unstructured":"Bonekamp D, Horton KM, Hruban RH, Fishman EK. Castleman disease: the great mimic. Radiographics. 2011, 31:1793-807. 10.1148\/rg.316115502","journal-title":"Radiographics"},{"key":"ref13","article-title":"Diseases with extremely elevated erythrocyte sedimentation rates in a secondary healthcare facility: retrospective cohort study","volume":"34","author":"Ohta R","year":"2017","unstructured":"Ohta R, Kaneko M, Hattori S.. Diseases with extremely elevated erythrocyte sedimentation rates in a secondary healthcare facility: retrospective cohort study. Shim Jr Med Sci. 2017, 34:27-33.","journal-title":"Shim Jr Med Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32834db525","article-title":"Castleman disease and associated autoimmune disease","volume":"24","author":"Muskardin TW","year":"2012","unstructured":"Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol. 2012, 24:76-83. 10.1097\/BOR.0b013e32834db525","journal-title":"Curr Opin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42514","article-title":"Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome initially diagnosed as fibromyalgia: a case report","volume":"15","author":"Ohta R","year":"2023","unstructured":"Ohta R, Sano C. Thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly (TAFRO) syndrome initially diagnosed as fibromyalgia: a case report. Cureus. 2023, 15:e42514. 10.7759\/cureus.42514","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192988-castleman-disease-in-an-older-patient-with-the-onset-of-right-pleural-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:09Z","timestamp":1707509169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192988-castleman-disease-in-an-older-patient-with-the-onset-of-right-pleural-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.47035","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,14]]}}}